Colorectal cancer is the second commonest malignancy in the western world, accounting for 20 000 deaths in the U.K. per year. Over the last 10 years, great strides have been made in our understanding of the molecular controls governing the transition from normal mucosa, through adenoma, and finally
DNA repair and personalized breast cancer therapy
β Scribed by Shu-Xia Li; Ashley Sjolund; Lyndsay Harris; Joann B. Sweasy
- Publisher
- John Wiley and Sons
- Year
- 2010
- Tongue
- English
- Weight
- 144 KB
- Volume
- 51
- Category
- Article
- ISSN
- 0893-6692
- DOI
- 10.1002/em.20606
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
Defective DNA repair capacity as measured by enumerating chromatid aberrations induced in G 2 phase by X-irradiation may explain increased risk of breast cancer among relatives of patients. In the present study, chromatid damage was determined in peripheral blood lymphocytes (PBL) following in vitro
## Abstract ## BACKGROUND Breast carcinoma is the most common cancer and the second leading cause of cancerβrelated deaths among women. The disease represents approximately 31% of all cancers in Puerto Rican women. Several DNA repair pathways are involved in preventing carcinogenesis. The current
## Abstract The capacity of peripheral blood lymphocytes to repair Xβrayβinduced DNA damage, manifest as chromatid damage 30β90 min after G~2~βphase Xβirradiation, was measured among available members of a family exhibiting a cluster of breastβcancer cases occurring in one generation. The cancer pa
Gene therapy has been proposed to have implications in the treatment of cancer. By genetically manipulating the hematopoietic stem cell compartment with genes that confer resistance to chemotherapeutic agents, the dose escalation that is necessary to effectively treat the cancers could potentially b